Post Approval Study of the AcrySof® IQ Toric Intraocular Lens (IOL) Models SN6AT6-SN6AT9

Post Approval Study of the AcrySof® IQ Toric High Cylinder Power IOL Models SN6AT6-SN6AT9

The purpose of this study is to evaluate the use of toric high cylinder power intraocular lenses in a larger population in clinical practice and assure the continued safety of these approved devices.

In this prospective, non-randomized, unmasked study, subjects with pre-existing corneal astigmatism ≥2.57 diopters will choose to be implanted with either the AcrySof® IQ Toric High Cylinder Power IOL or the AcrySof® IQ Aspheric NATURAL monofocal IOL.

Inclusion Criteria:

• Diagnosed with bilateral cataracts and in the targeted astigmatism range.
• Planned cataract removal by phacoemulsification.
• Pupil size greater than or equal to 6 mm after dilation.
• Able to undergo second eye surgery within 30 days of first eye surgery.
• Other protocol-defined inclusion criteria may apply.

Exclusion Criteria:

• Irregular corneal astigmatism.
• Any inflammation or swelling of the cornea.
• Any corneal abnormality other than regular corneal astigmatism.
• Previous corneal refractive surgery.
• Amblyopia.
• Diabetic retinopathy.
• Uncontrolled glaucoma.
• Currently participating in another investigational drug or device study that may confound the results of this investigation.
• Other protocol-defined exclusion criteria may apply.